These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32654812)

  • 41. Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.
    Ketteler M; Elder GJ; Evenepoel P; Ix JH; Jamal SA; Lafage-Proust MH; Shroff R; Thadhani RI; Tonelli MA; Kasiske BL; Wheeler DC; Leonard MB
    Kidney Int; 2015 Mar; 87(3):502-28. PubMed ID: 25651364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aymé S, Bockenhauer D, Day S, et al. Common Elements in Rare Kidney Diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017;92:796-808.
    Kidney Int; 2017 Dec; 92(6):1558. PubMed ID: 29153144
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute kidney injury in leptospirosis: the Kidney Disease Improving Global Outcomes (KDIGO) criteria and mortality
.
    Teles F; de Mendonça Uchôa JV; Mirelli Barreto Mendonça D; Falcão Pedrosa Costa A
    Clin Nephrol; 2016 Dec; 86 (2016)(12):303-309. PubMed ID: 27805562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Chan CT; Blankestijn PJ; Dember LM; Gallieni M; Harris DCH; Lok CE; Mehrotra R; Stevens PE; Wang AY; Cheung M; Wheeler DC; Winkelmayer WC; Pollock CA;
    Kidney Int; 2019 Jul; 96(1):37-47. PubMed ID: 30987837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report.
    Wang AY; Akizawa T; Bavanandan S; Hamano T; Liew A; Lu KC; Lumlertgul D; Oh KH; Zhao MH; Ka-Shun Fung S; Obi Y; Sumida K; Choong LHL; Goh BL; Hao CM; Kwon YJ; Tarng DC; Zuo L; Wheeler DC; Tsukamoto Y; Fukagawa M
    Kidney Int Rep; 2019 Nov; 4(11):1523-1537. PubMed ID: 31890994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
    Locatelli F; Nissenson AR; Barrett BJ; Walker RG; Wheeler DC; Eckardt KU; Lameire NH; Eknoyan G
    Kidney Int; 2008 Nov; 74(10):1237-40. PubMed ID: 18596731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
    Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
    Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
    Levey AS; Eckardt KU; Tsukamoto Y; Levin A; Coresh J; Rossert J; De Zeeuw D; Hostetter TH; Lameire N; Eknoyan G
    Kidney Int; 2005 Jun; 67(6):2089-100. PubMed ID: 15882252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Perkovic V; Agarwal R; Fioretto P; Hemmelgarn BR; Levin A; Thomas MC; Wanner C; Kasiske BL; Wheeler DC; Groop PH;
    Kidney Int; 2016 Dec; 90(6):1175-1183. PubMed ID: 27884312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of RIFLE, AKIN, and KDIGO classifications for assessing prognosis of patients on extracorporeal membrane oxygenation.
    Tsai TY; Chien H; Tsai FC; Pan HC; Yang HY; Lee SY; Hsu HH; Fang JT; Yang CW; Chen YC
    J Formos Med Assoc; 2017 Nov; 116(11):844-851. PubMed ID: 28874330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions.
    Sutherland SM; Byrnes JJ; Kothari M; Longhurst CA; Dutta S; Garcia P; Goldstein SL
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):554-61. PubMed ID: 25649155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute kidney injury based on KDIGO (Kidney Disease Improving Global Outcomes) criteria in patients with elevated baseline serum creatinine undergoing cardiac surgery.
    Machado MN; Nakazone MA; Maia LN
    Rev Bras Cir Cardiovasc; 2014; 29(3):299-307. PubMed ID: 25372901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement.
    Heemann U; Abramowicz D; Spasovski G; Vanholder R;
    Nephrol Dial Transplant; 2011 Jul; 26(7):2099-106. PubMed ID: 21555392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and mortality of postoperative acute kidney injury in non-dialysis patients: comparison between the AKIN and KDIGO criteria.
    Wu HC; Lee LC; Wang WJ
    Ren Fail; 2016; 38(2):330-9. PubMed ID: 26768125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of acute kidney injury according to the modified KDIGO criteria in infants after cardiac surgery for congenital heart disease.
    Ueno K; Seki S; Shiokawa N; Matsuba T; Miyazono A; Hazeki D; Imoto Y; Kawano Y
    Nephrology (Carlton); 2019 Mar; 24(3):294-300. PubMed ID: 29451341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.
    Goldsmith DJ; Covic A; Fouque D; Locatelli F; Olgaard K; Rodriguez M; Spasovski G; Urena P; Zoccali C; London GM; Vanholder R
    Nephrol Dial Transplant; 2010 Dec; 25(12):3823-31. PubMed ID: 20829401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
    Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kidney Disease: Improving Global Outcomes--an update.
    Kasiske BL; Wheeler DC
    Nephrol Dial Transplant; 2014 Apr; 29(4):763-9. PubMed ID: 24286979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.